QMS Medical Allied Services Limited

As of June 30, 2026, QMS Medical Allied Services Limited carries a market capitalization of 1.97B, placing it among publicly traded companies globally. Its enterprise value stands at 1.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, QMS Medical Allied Services Limited has 19.34M shares outstanding.

As of June 30, 2026, QMS Medical Allied Services Limited trades at a trailing price-to-earnings ratio of 16.63.

As of June 30, 2026, QMS Medical Allied Services Limited trades at an EV/EBITDA multiple of 7.10 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.08 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 8.50 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.97B versus a market cap of 1.97B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 3.25M in revenue per employee across its workforce of 563.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, QMS Medical Allied Services Limited recorded 47.87M in income tax expense. That works out to an effective tax rate of 27.34, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 175.08M, leaving 119.57M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, QMS Medical Allied Services Limited's stock has gained approximately 23.82% over the past 52 weeks.

Over the twelve months ended June 30, 2026, QMS Medical Allied Services Limited generated 1.83B in revenue and converted that into 119.57M in net income, yielding earnings per share of 6.52. EBITDA reached 277.44M, while operating income came in at 231.95M.

Over the twelve months ended June 30, 2026, QMS Medical Allied Services Limited posted a gross margin of 49.32, reflecting its pricing power and cost economics. The operating margin of 12.66 and net profit margin of 6.52 provide insight into operational efficiency.